BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23959725)

  • 1. Liver X receptor agonist T0901317 enhanced peroxisome proliferator-activated receptor-delta expression and fatty acid oxidation in rat skeletal muscle.
    Baranowski M; Blachnio-Zabielska AU; Zabielski P; Harasim E; Harasiuk D; Chabowski A; Gorski J
    J Physiol Pharmacol; 2013 Jun; 64(3):289-97. PubMed ID: 23959725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-sensitizing effect of LXR agonist T0901317 in high-fat fed rats is associated with restored muscle GLUT4 expression and insulin-stimulated AS160 phosphorylation.
    Baranowski M; Zabielski P; Błachnio-Zabielska AU; Harasim E; Chabowski A; Górski J
    Cell Physiol Biochem; 2014; 33(4):1047-57. PubMed ID: 24732673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LXR agonist T0901317-Induced hyperlipidemia does not lead to lipid accumulation in the rat heart.
    Harasiuk D; Baranowski M; Zabielski P; Chabowski A; Górski J
    Cell Physiol Biochem; 2015; 35(3):1095-106. PubMed ID: 25659329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo.
    Beyer TP; Schmidt RJ; Foxworthy P; Zhang Y; Dai J; Bensch WR; Kauffman RF; Gao H; Ryan TP; Jiang XC; Karathanasis SK; Eacho PI; Cao G
    J Pharmacol Exp Ther; 2004 Jun; 309(3):861-8. PubMed ID: 14960661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal liver X receptor activation acutely induces lipogenesis but does not affect plasma lipid response to a high-fat diet in adult mice.
    van Straten EM; van Meer H; Huijkman NC; van Dijk TH; Baller JF; Verkade HJ; Kuipers F; Plösch T
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1171-8. PubMed ID: 19724022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LXR activation prevents exhaustive exercise-induced hypoglycaemia and spares muscle glycogen but does not enhance running endurance in untrained rats.
    Baranowski M; Zabielski P; Błachnio-Zabielska AU; Harasiuk D; Górski J
    Acta Physiol (Oxf); 2011 Mar; 201(3):373-9. PubMed ID: 20887359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
    Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα.
    Ducheix S; Podechard N; Lasserre F; Polizzi A; Pommier A; Murzilli S; Di Lisio C; D'Amore S; Bertrand-Michel J; Montagner A; Pineau T; Loiseau N; Lobaccaro JM; Martin PG; Guillou H
    Biochimie; 2013 Mar; 95(3):556-67. PubMed ID: 23063693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway.
    Kase ET; Wensaas AJ; Aas V; Højlund K; Levin K; Thoresen GH; Beck-Nielsen H; Rustan AC; Gaster M
    Diabetes; 2005 Apr; 54(4):1108-15. PubMed ID: 15793250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARα-LXR as a novel metabolostatic signalling axis in skeletal muscle that acts to optimize substrate selection in response to nutrient status.
    Caton PW; Holness MJ; Bishop-Bailey D; Sugden MC
    Biochem J; 2011 Aug; 437(3):521-30. PubMed ID: 21609322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 22-Hydroxycholesterols regulate lipid metabolism differently than T0901317 in human myotubes.
    Kase ET; Andersen B; Nebb HI; Rustan AC; Thoresen GH
    Biochim Biophys Acta; 2006 Dec; 1761(12):1515-22. PubMed ID: 17055780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver X receptor agonist T0901317 induced liver perturbation in zebrafish: histological, gene set enrichment and expression analyses.
    Sukardi H; Zhang X; Lui EY; Ung CY; Mathavan S; Gong Z; Lam SH
    Biochim Biophys Acta; 2012 Jan; 1820(1):33-43. PubMed ID: 22047996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAAT/enhancer binding protein β deletion increases mitochondrial function and protects mice from LXR-induced hepatic steatosis.
    Rahman SM; Choudhury M; Janssen RC; Baquero KC; Miyazaki M; Friedman JE
    Biochem Biophys Res Commun; 2013 Jan; 430(1):336-9. PubMed ID: 23159614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.
    Gao M; Bu L; Ma Y; Liu D
    PLoS One; 2013; 8(6):e65641. PubMed ID: 23762402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
    Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
    Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X Receptor Agonist TO901317 Prevents Diacylglycerols Accumulation in the Heart of Streptozotocin-Diabetic Rats.
    Harasiuk D; Baranowski M; Zabielski P; Chabowski A; Górski J
    Cell Physiol Biochem; 2016; 39(1):350-9. PubMed ID: 27352290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor delta facilitates lipid secretion and catabolism of fatty acids in dairy goat mammary epithelial cells.
    Shi HB; Zhang CH; Zhao W; Luo J; Loor JJ
    J Dairy Sci; 2017 Jan; 100(1):797-806. PubMed ID: 27865496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of bile acid, cholesterol, and fatty acid synthesis in chicken primary hepatocytes by different concentrations of T0901317, an agonist of liver X receptors.
    Sato K; Kamada T
    Comp Biochem Physiol A Mol Integr Physiol; 2011 Feb; 158(2):201-6. PubMed ID: 21056113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.